ES2143675T3 - Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. - Google Patents

Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.

Info

Publication number
ES2143675T3
ES2143675T3 ES96101976T ES96101976T ES2143675T3 ES 2143675 T3 ES2143675 T3 ES 2143675T3 ES 96101976 T ES96101976 T ES 96101976T ES 96101976 T ES96101976 T ES 96101976T ES 2143675 T3 ES2143675 T3 ES 2143675T3
Authority
ES
Spain
Prior art keywords
medicinal product
substituted
atoms
well
benzenosulphonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96101976T
Other languages
English (en)
Inventor
Heinrich Christian Dr Englert
Uwe Dr Gerlach
Dieter Dr Mania
Heinz Dr Gogelein
Joachim Dr Kaiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2143675T3 publication Critical patent/ES2143675T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

BENZOLSULFONILUREAS Y -TIOUREAS SUSTITUIDAS DE FORMULA I, DONDE R(1) ES HIDROGENO, METILO O TRIFLUOROMETILO; R(2) ALCOXI CON 4, 5, 6, 7, 8, 9, O 10 ATOMOS DE C, DONDE DE 1 A 6 ATOMOS DE CARBONO NO ESTAN SUSTITUIDOS POR LOS HETEROATOMOS O, S O NH; E ES OXIGENO O AZUFRE; Y ES -[CR(3){SUB,2}]{SUB,1-4}; SIENDO R(3) HIDROGENO O LAQUILO CON 1 O 2 ATOMOS DE C; X ES HIDROGENO, HALOGENO O ALQUILO CON 1, 2, 3, 4, 5 O 6 ATOMOS DE C; Z ES HALOGENO, ALCOXI CON 1, 2, 3 O 4 ATOMOS DE C O ALQUILO CON 1, 2, 3 O 4 ATOMOS DE C. ASI COMO SUS SALES FARMACEUTICAMENTE ACEPTABLES QUE TIENEN EFECTO SOBRE EL SISTEMA CARDIOVASCULAR.
ES96101976T 1995-02-17 1996-02-12 Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene. Expired - Lifetime ES2143675T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19505397A DE19505397A1 (de) 1995-02-17 1995-02-17 Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
ES2143675T3 true ES2143675T3 (es) 2000-05-16

Family

ID=7754249

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96101976T Expired - Lifetime ES2143675T3 (es) 1995-02-17 1996-02-12 Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.

Country Status (31)

Country Link
US (1) US5652268A (es)
EP (1) EP0727416B1 (es)
JP (1) JP3905568B2 (es)
KR (1) KR100450914B1 (es)
CN (1) CN1058705C (es)
AR (1) AR003924A1 (es)
AT (1) ATE189213T1 (es)
AU (1) AU700793B2 (es)
BR (1) BR9600778A (es)
CA (1) CA2169694C (es)
CY (1) CY2220B1 (es)
CZ (1) CZ291271B6 (es)
DE (2) DE19505397A1 (es)
DK (1) DK0727416T3 (es)
ES (1) ES2143675T3 (es)
FI (1) FI120393B (es)
GR (1) GR3033049T3 (es)
HR (1) HRP960077B1 (es)
HU (1) HU226463B1 (es)
IL (1) IL117150A (es)
MY (1) MY113431A (es)
NO (1) NO305751B1 (es)
NZ (1) NZ280991A (es)
PL (1) PL181950B1 (es)
PT (1) PT727416E (es)
RU (1) RU2198163C2 (es)
SI (1) SI9600049B (es)
SK (1) SK281605B6 (es)
TR (1) TR199600118A2 (es)
TW (1) TW355183B (es)
ZA (1) ZA961231B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19647000A1 (de) * 1996-11-14 1998-05-20 Hoechst Ag 3-Amido-chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
HK1040187B (zh) * 1998-09-10 2005-09-02 萨诺费－阿文蒂斯德国有限公司 苯磺酰(硫)脲與β-受體阻滯劑聯合在製備用於心臟迷走神經機能障礙治療和預防的藥物中的用途
DE19917233A1 (de) * 1999-04-16 2000-10-19 Aventis Pharma Gmbh Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
DE19923086A1 (de) 1999-05-20 2000-11-23 Aventis Pharma Gmbh Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054482A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10129704A1 (de) * 2001-06-22 2003-01-02 Aventis Pharma Gmbh Verwendung von Benzolsulfonyl(thio)harnstoffen in der Behandlung des septischen Schocks
DE102004061017A1 (de) * 2004-12-18 2006-06-22 Sanofi-Aventis Deutschland Gmbh Piperidinsulfonylharnstoffe und -thioharnstoffe, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
CN101679191B (zh) * 2007-06-05 2014-03-12 塞诺菲-安万特股份有限公司 二杂芳基环己烷衍生物、其制备方法、用途及含有它们的药用组合物
US20250145564A1 (en) * 2021-08-16 2025-05-08 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Sulfonylurea compound, preparation method therefor, and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1198354B (de) * 1963-09-25 1965-08-12 Hoechst Ag Verfahren zur Herstellung von Benzol-sulfonylharnstoffen
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
BE754454A (fr) * 1969-08-06 1971-02-05 Bayer Ag Nouveaux composes hypoglycemiques du type d'arylsulfonylurees et d'arylsulfonylsemicarbazides contenant des groupes carbonamide
DE2413514C3 (de) * 1974-03-21 1982-03-04 Hoechst Ag, 6000 Frankfurt N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
US4927453A (en) * 1986-10-17 1990-05-22 E. I. Du Pont De Nemours And Company Herbicidal sulfonamides
DE59401361D1 (de) * 1993-02-23 1997-02-06 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika

Also Published As

Publication number Publication date
CA2169694C (en) 2008-05-20
SK21196A3 (en) 1996-10-02
MY113431A (en) 2002-02-28
DE59604262D1 (de) 2000-03-02
FI120393B (fi) 2009-10-15
BR9600778A (pt) 1997-12-23
HK1011965A1 (en) 1999-07-23
CZ43696A3 (en) 1996-09-11
ZA961231B (en) 1996-08-27
GR3033049T3 (en) 2000-08-31
DK0727416T3 (da) 2000-06-13
TW355183B (en) 1999-04-01
SK281605B6 (sk) 2001-05-10
HU226463B1 (en) 2008-12-29
EP0727416B1 (de) 2000-01-26
NO960627L (no) 1996-08-19
PL312528A1 (en) 1996-08-19
ATE189213T1 (de) 2000-02-15
AU4556096A (en) 1996-08-29
FI960689A0 (fi) 1996-02-15
RU2198163C2 (ru) 2003-02-10
NZ280991A (en) 1997-01-29
NO305751B1 (no) 1999-07-19
HRP960077B1 (en) 2001-06-30
IL117150A (en) 2001-03-19
AR003924A1 (es) 1998-09-30
EP0727416A1 (de) 1996-08-21
IL117150A0 (en) 1996-06-18
NO960627D0 (no) 1996-02-16
CN1134414A (zh) 1996-10-30
CN1058705C (zh) 2000-11-22
CZ291271B6 (cs) 2003-01-15
HU9503879D0 (en) 1996-02-28
US5652268A (en) 1997-07-29
PT727416E (pt) 2000-06-30
SI9600049B (en) 2001-12-31
FI960689L (fi) 1996-08-18
HRP960077A2 (en) 1997-12-31
AU700793B2 (en) 1999-01-14
KR100450914B1 (ko) 2004-12-03
PL181950B1 (pl) 2001-10-31
CA2169694A1 (en) 1996-08-18
JP3905568B2 (ja) 2007-04-18
CY2220B1 (en) 2003-04-18
JPH08245554A (ja) 1996-09-24
TR199600118A2 (tr) 1996-10-21
DE19505397A1 (de) 1996-08-22
SI9600049A (en) 1996-10-31
HUT73973A (en) 1996-10-28
KR960031433A (ko) 1996-09-17

Similar Documents

Publication Publication Date Title
ATE286735T1 (de) Verwendung von a-glycosylceramiden zur herstellung eines therapeutischen mittelszur behandlung von autoimmunkrankheiten
DE69100079D1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
ES2150544T3 (es) Dihidropiridinas de accion breve.
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2159922T3 (es) Nuevos derivados de bencimidazol, de benzoxazol y de benzotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR8200949A (pt) Imidazodiazepinas,substancias farmaceutica ativas,processo para a fabricacao de compostos,medicamentos,medicamento esquistossomicidamente ativo e uso de compostos
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2157315T3 (es) Derivados de 2-arilalquenil-azacicloalcanos ligandos a los receptores sigma, su procedimiento de preparacion y su aplicacion en terapeutica.
MX9301404A (es) Derivados de 2-oxoquinolina, procedimiento para su preparacion, preparado farmaceutico que los contiene y procedimiento para la obtencion de tal preparado farmaceutico.
AR003924A1 (es) Bencensulfonilureas y bencensulfoniltioureas sustituidas, procedimiento para su preparacion, empleo de las mismas y agente curativo que las contiene
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
BR0307008A (pt) N-aril-4,5-dia-minopirazóis e agentes de tingimento que contêm esses compostos
ES2133153T3 (es) Nuevos depsipeptidos ciclicos con 18 atomos de anillo, y su empleo para el combate de endoparasitos.
DZ1726A1 (fr) Médicament contenant des composés imidazol-1-yliques.
PT89082A (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico
ES2077473T3 (es) Nuevos compuestos tiocromanicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
ES2169909T3 (es) 5-hidroximetil-2-aminotetralinas como agentes cardiovasculares.
ES2155546T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y el uso de preparaciones farmaceuticas basadas en estos compuestos, asi como medicamentos que los contienen.
ATE40349T1 (de) Difluorcyclopropanderivate, verfahren zu ihrer herstellung sowie schaedlingsbekaempfungsmittel enthaltend diese verbindungen.
ES2151614T3 (es) Bencenosulfonilureas y bencenosulfoniltioureas sustituidas, procedimiento para su preparacion, su utilizacion para la produccion de preparados farmaceuticos y medicamentos que las contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 727416

Country of ref document: ES